Motilal Oswal has initiated coverage on Aster DM Quality Care with a Buy rating and a target price of Rs 910, arguing that merger synergies, capacity expansion and improving operating metrics should drive a sustained earnings re-rating. The brokerage expects revenue, EBITDA and PAT to compound at 19.5%, 25% and 33%, respectively, through FY28, placing the hospital chain among the more attractive growth stories in India’s healthcare services space.
"Motilal Oswal Sees Aster DM EBITDA Rising 25% CAGR Through FY28, Sets Rs 910 Target"
Motilal Oswal has initiated coverage on Aster DM Quality Care with a Buy rating and a target price of Rs 910, arguing that merger synergies, capacity expansion and improving operating metrics should drive a sustained earnings re-rating. The brokerage expects revenue, EBITDA and PAT to compound at 19.5%, 25% and 33%, respectively, through FY28, placing the hospital chain among the more attractive growth stories in India’s healthcare services space.
Motilal Oswal Sees Aster DM EBITDA Rising 25% CAGR Through FY28, Sets Rs 910 Target
RDU Global Wire
Macro Economy & Fiscal Policy Desk
Motilal Oswal has initiated coverage on Aster DM Quality Care with a Buy rating and a target price of Rs 910, arguing that merger synergies, capacity expansion and improving operating metrics should drive a sustained earnings re-rating. The brokerage expects revenue, EBITDA and PAT to compound at 19.5%, 25% and 33%, respectively, through FY28, placing the hospital chain among the more attractive growth stories in India’s healthcare services space.
Editorial & Verification Notice
Reported by RDU Global Correspondent. Formatted and verified using real-time institutional and journalistic wire feeds. Independent reporting adhering to the RDU Global Editorial Code of Conduct.
Related Coverage
Health Ministry Proposes Drug Rules Amendment to Ease Regulation of Medicinal Gases, Empty Gelatin Capsules and Disinfectant Liquids
India’s Health Ministry has proposed amendments to the Drugs Rules, 1945, aimed at introducing greater regulatory flexibility for medicinal gases, empty gelatin capsules and disinfectant liquids. The move signals a broader effort to streamline compliance while preserving quality and safety oversight across essential pharmaceutical inputs.
Tech Is Powering a Healthier Investment Era as Healthcare Enters a New Digital Age
Healthcare is moving into a new phase in which sensors, wearables, 3D-printed skin, reconstructed organs and data-driven clinical trials are no longer futuristic concepts but investable technologies. For markets and wealth creators, the shift is opening a broad opportunity set across medtech, biotech, diagnostics and digital health, while also raising the bar for regulation, validation and commercial scale.
India Launches Statewide Drive to Protect Children Against Tetanus and Diphtheria
India has begun a statewide vaccination drive aimed at strengthening protection for children aged 10 and 16 against tetanus and diphtheria, two potentially serious vaccine-preventable diseases. The initiative builds on early-life immunisation coverage, with officials emphasising that the TD vaccine provides an additional shield after children receive Pentavalent vaccines in infancy.
